ChromaCode uses patented mathematical methods and algorithms to enrich signal processing from the most popular life science instrumentation. Their initial products enable high multiplexing of biological tests using existing real-time PCR instruments at a very low cost.
- Year invested 2017
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Website chromacode.com/
- Company Status Private